Receiving a multiple sclerosis (MS) diagnosis can be overwhelming. But while you may initially feel frightened and confused, rest assured that you’re not alone. According to a study supported by the National Multiple Sclerosis Society (NMSS), nearly 1 million adults in the United States were living with MS as of 2017. The good news is that there are more treatment options and resources than ever before.
In fact, the number of available treatments for MS is at an all-time high. “The field has exploded, as has the science,” says Farrah Mateen, M.D., a board-certified neurologist who specializes in MS at Massachusetts General Hospital, in Boston.
“We currently have more than 25 drugs for MS. Not so long ago, we had basically only the ABC drugs,” Mateen says, referring to Avonex, Betaseron, and Copaxone, the first three disease-modifying treatments for MS, which became available in the early-to-mid-1990s.